SCHEDULE 3 Amendments consequential on the establishment of the National Health Service Commissioning Board and clinical commissioning groups

8 The Medicines for Human Use (Clinical Trials) Regulations 2004
(1) The Medicines for Human Use (Clinical Trials) Regulations 2004 are amended as follows.
S.I. 2004/1031. Relevant amending instruments are S.I. 2006/562, S.I. 2008/941 and S.I. 2011/2581.
(2) In regulation 2(1) (interpretation), in the definition of “health service body”—
(a) in paragraph (b), after “Primary Care Trust” insert “, clinical commissioning group”; and
(b) after paragraph (b) insert—

“(ba) the National Health Service Commissioning Board,”

.
(3) In Schedule 2 (additional provisions relating to Ethics Committees)—
(a) in paragraph 3(5)(b)(iii), at the end of paragraph (bb) insert—

“; or
(cc) the governing body of a clinical commissioning group”

; and
(b) in paragraph 6(6)(a)(ii), after “health service body” insert “or the governing body of a clinical commissioning group”.